Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1074-1081.DOI: 10.12114/j.issn.1007-9572.2023.0435
• Original Research • Previous Articles Next Articles
Received:
2023-07-23
Revised:
2023-10-15
Published:
2024-03-20
Online:
2023-12-19
Contact:
SHEN Shanmei
通讯作者:
沈山梅
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0435
组别 | 例数 | 年龄(岁) | BMI (kg/m2) | 血清尿酸(μmol/L) | 血清肌酐(μmol/L) | 血清尿酸/肌酐 | 丙氨酸氨基转移酶(U/L) | 天冬氨酸氨基转移酶(U/L) |
---|---|---|---|---|---|---|---|---|
正常组 | 344 | 29(27,32) | 26.4(24.4,28.6) | 294.0(241.3,349.0) | 43.0(39.0,49.0) | 6.7(5.8,7.7) | 11.9(9.0,17.2) | 18.0(14.4,23.4) |
不良结局组 | 399 | 31(28,35) | 28.3(25.8,30.9) | 310.0(268.0,366.0) | 45.0(39.0,50.5) | 7.0(5.9,8.1) | 11.6(8.6,17.4) | 17.2(13.9,23.0) |
Z值 | -5.302 | -6.588 | -3.652 | -1.627 | -3.174 | -0.461 | -1.417 | |
P值 | <0.001 | <0.001 | <0.001 | 0.104 | 0.002 | 0.645 | 0.156 | |
组别 | 空腹血糖(mmol/L) | 1 h血糖(mmol/L) | 2 h血糖(mmol/L) | 糖化血红蛋白(%) | 三酰甘油(mmol/L) | 总胆固醇(mmol/L) | 低密度脂蛋白(mmol/L) | 高密度脂蛋白(mmol/L) |
正常组 | 4.4(4.1,4.7) | 9.0(7.3,10.1) | 7.7(6.2,8.7) | 5.3(5.0,5.6) | 2.7(2.1,3.5) | 5.8(4.9,6.5) | 2.8(2.2,3.5) | 1.7(1.4,2.0) |
不良结局组 | 4.5(4.2,4.7) | 8.6(7.3,10.0) | 7.2(6.2,8.6) | 5.3(5.1,5.7) | 2.9(2.3,3.7) | 5.7(5.0,6.6) | 2.9(2.3,3.5) | 1.7(1.4,1.9) |
Z值 | -1.217 | -1.144 | -1.436 | -0.562 | -2.693 | -0.598 | -1.169 | -1.324 |
P值 | 0.224 | 0.252 | 0.151 | 0.574 | 0.007 | 0.550 | 0.242 | 0.185 |
Table 1 Comparison of baseline data between the two groups of pregnant women
组别 | 例数 | 年龄(岁) | BMI (kg/m2) | 血清尿酸(μmol/L) | 血清肌酐(μmol/L) | 血清尿酸/肌酐 | 丙氨酸氨基转移酶(U/L) | 天冬氨酸氨基转移酶(U/L) |
---|---|---|---|---|---|---|---|---|
正常组 | 344 | 29(27,32) | 26.4(24.4,28.6) | 294.0(241.3,349.0) | 43.0(39.0,49.0) | 6.7(5.8,7.7) | 11.9(9.0,17.2) | 18.0(14.4,23.4) |
不良结局组 | 399 | 31(28,35) | 28.3(25.8,30.9) | 310.0(268.0,366.0) | 45.0(39.0,50.5) | 7.0(5.9,8.1) | 11.6(8.6,17.4) | 17.2(13.9,23.0) |
Z值 | -5.302 | -6.588 | -3.652 | -1.627 | -3.174 | -0.461 | -1.417 | |
P值 | <0.001 | <0.001 | <0.001 | 0.104 | 0.002 | 0.645 | 0.156 | |
组别 | 空腹血糖(mmol/L) | 1 h血糖(mmol/L) | 2 h血糖(mmol/L) | 糖化血红蛋白(%) | 三酰甘油(mmol/L) | 总胆固醇(mmol/L) | 低密度脂蛋白(mmol/L) | 高密度脂蛋白(mmol/L) |
正常组 | 4.4(4.1,4.7) | 9.0(7.3,10.1) | 7.7(6.2,8.7) | 5.3(5.0,5.6) | 2.7(2.1,3.5) | 5.8(4.9,6.5) | 2.8(2.2,3.5) | 1.7(1.4,2.0) |
不良结局组 | 4.5(4.2,4.7) | 8.6(7.3,10.0) | 7.2(6.2,8.6) | 5.3(5.1,5.7) | 2.9(2.3,3.7) | 5.7(5.0,6.6) | 2.9(2.3,3.5) | 1.7(1.4,1.9) |
Z值 | -1.217 | -1.144 | -1.436 | -0.562 | -2.693 | -0.598 | -1.169 | -1.324 |
P值 | 0.224 | 0.252 | 0.151 | 0.574 | 0.007 | 0.550 | 0.242 | 0.185 |
变量 | 剖宫产 | 子痫前期 | ||||
---|---|---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |||
血清尿酸(以Q1为参照) | ||||||
Q2 | 1.37(0.96~1.97) | 1.27(0.86~1.89) | 2.16(1.09~4.29)a | 1.46(0.72~2.98) | ||
Q3 | 1.42(0.94~2.15) | 1.26(0.79~1.98) | 6.49(3.26~12.89)a | 4.41(2.16~8.99)a | ||
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 1.18(0.82~1.70) | 1.20(0.80~1.77) | 2.64(1.34~5.17)a | 2.33(1.13~4.79)a | ||
q3 | 1.66(1.10~2.52)a | 1.52(0.96~2.39) | 4.85(2.41~9.75)a | 3.56(1.68~7.56)a | ||
变量 | 早产 | 宫内生长受限 | 巨大儿 | |||
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸(以Q1为参照) | ||||||
Q2 | 1.12(0.58~2.17) | 0.97(0.49~1.91) | 1.36(0.48~3.87) | 1.92(0.60~6.11) | 1.08(0.56~2.09) | 0.92(0.45~1.86) |
Q3 | 2.04(1.03~4.05)a | 1.58(0.77~3.25) | 2.33(0.79~6.83) | 3.59(1.08~11.96)a | 1.02(0.47~2.21) | 0.85(0.37~1.93) |
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 1.09(0.54~2.21) | 0.99(0.48~2.05) | 2.38(0.68~8.38) | 2.35(0.65~8.50) | 0.66(0.35~1.22) | 0.58(0.30~1.12) |
q3 | 3.05(1.52~6.14)a | 2.76(1.33~5.71)a | 4.26(1.18~15.34)a | 5.15(1.39~19.14)a | 0.61(0.29~1.30) | 0.43(0.19~0.98)a |
变量 | 低体质量儿 | 大于胎龄儿 | 小于胎龄儿 | |||
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸(以Q1为参照) | ||||||
Q2 | 0.93(0.31~2.82) | 0.83(0.26~2.59) | 1.08(0.53~2.21) | 0.93(0.43~1.99) | 0.81(0.31~2.12) | 0.74(0.27~2.01) |
Q3 | 2.55(0.88~7.39) | 2.35(0.78~7.03) | 0.93(0.40~2.17) | 0.79(0.32~1.93) | 2.46(0.99~6.13) | 2.19(0.85~5.66) |
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 0.70(0.26~1.88) | 0.61(0.22~1.69) | 0.69(0.36~1.36) | 0.62(0.31~1.26) | 0.80(0.33~1.97) | 0.72(0.29~1.82) |
q3 | 1.32(0.48~3.61) | 1.11(0.38~3.22) | 0.55(0.24~1.27) | 0.38(0.15~0.96)a | 1.69(0.68~4.18) | 1.38(0.53~3.61) |
Table 2 Multivariate Logistic regression of the effect of serum uric acid,serum uric acid/creatinine ratio on adverse outcomes
变量 | 剖宫产 | 子痫前期 | ||||
---|---|---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |||
血清尿酸(以Q1为参照) | ||||||
Q2 | 1.37(0.96~1.97) | 1.27(0.86~1.89) | 2.16(1.09~4.29)a | 1.46(0.72~2.98) | ||
Q3 | 1.42(0.94~2.15) | 1.26(0.79~1.98) | 6.49(3.26~12.89)a | 4.41(2.16~8.99)a | ||
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 1.18(0.82~1.70) | 1.20(0.80~1.77) | 2.64(1.34~5.17)a | 2.33(1.13~4.79)a | ||
q3 | 1.66(1.10~2.52)a | 1.52(0.96~2.39) | 4.85(2.41~9.75)a | 3.56(1.68~7.56)a | ||
变量 | 早产 | 宫内生长受限 | 巨大儿 | |||
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸(以Q1为参照) | ||||||
Q2 | 1.12(0.58~2.17) | 0.97(0.49~1.91) | 1.36(0.48~3.87) | 1.92(0.60~6.11) | 1.08(0.56~2.09) | 0.92(0.45~1.86) |
Q3 | 2.04(1.03~4.05)a | 1.58(0.77~3.25) | 2.33(0.79~6.83) | 3.59(1.08~11.96)a | 1.02(0.47~2.21) | 0.85(0.37~1.93) |
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 1.09(0.54~2.21) | 0.99(0.48~2.05) | 2.38(0.68~8.38) | 2.35(0.65~8.50) | 0.66(0.35~1.22) | 0.58(0.30~1.12) |
q3 | 3.05(1.52~6.14)a | 2.76(1.33~5.71)a | 4.26(1.18~15.34)a | 5.15(1.39~19.14)a | 0.61(0.29~1.30) | 0.43(0.19~0.98)a |
变量 | 低体质量儿 | 大于胎龄儿 | 小于胎龄儿 | |||
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸(以Q1为参照) | ||||||
Q2 | 0.93(0.31~2.82) | 0.83(0.26~2.59) | 1.08(0.53~2.21) | 0.93(0.43~1.99) | 0.81(0.31~2.12) | 0.74(0.27~2.01) |
Q3 | 2.55(0.88~7.39) | 2.35(0.78~7.03) | 0.93(0.40~2.17) | 0.79(0.32~1.93) | 2.46(0.99~6.13) | 2.19(0.85~5.66) |
血清尿酸/肌酐(以q1为参照) | ||||||
q2 | 0.70(0.26~1.88) | 0.61(0.22~1.69) | 0.69(0.36~1.36) | 0.62(0.31~1.26) | 0.80(0.33~1.97) | 0.72(0.29~1.82) |
q3 | 1.32(0.48~3.61) | 1.11(0.38~3.22) | 0.55(0.24~1.27) | 0.38(0.15~0.96)a | 1.69(0.68~4.18) | 1.38(0.53~3.61) |
变量 | 子痫前期 | 早产 | ||
---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸 | ||||
年龄<30岁(以Q1为参照) | ||||
Q2 | 1.65(0.63~4.34) | 1.19(0.44~3.29) | 1.42(0.43~4.67) | 1.29(0.38~4.33) |
Q3 | 5.09(1.96~13.23)a | 3.21(1.18~8.74)a | 3.48(1.08~11.25)a | 2.58(0.73~9.13) |
年龄≥30岁(以Q1为参照) | ||||
Q2 | 2.75(1.02~7.38)a | 1.74(0.62~4.87) | 0.97(0.44~2.15) | 0.82(0.36~1.88) |
Q3 | 8.17(3.02~22.14)a | 5.68(2.03~15.92)a | 1.47(0.62~3.48) | 1.02(0.40~2.56) |
血清尿酸/肌酐 | ||||
年龄<30岁(以q1为参照) | ||||
q2 | 1.97(0.71~5.42) | 1.41(0.49~4.10) | 1.18(0.31~4.59) | 1.03(0.25~18.63) |
q3 | 4.42(1.57~12.46)a | 2.78(0.93~8.25) | 5.28(1.47~19.02)a | 3.59(0.93~13.79) |
年龄≥30岁(以q1为参照) | ||||
q2 | 3.32(1.34~8.21)a | 3.38(1.25~9.17)a | 1.11(0.48~2.57) | 1.01(0.43~2.39) |
q3 | 5.21(2.02~13.44)a | 4.24(1.48~12.16)a | 2.31(0.98~5.45) | 1.91(0.77~4.71) |
Table 3 Effects of serum uric acid and serum uric acid/creatinine ratio on preeclampsia and preterm birth in different age subgroups
变量 | 子痫前期 | 早产 | ||
---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸 | ||||
年龄<30岁(以Q1为参照) | ||||
Q2 | 1.65(0.63~4.34) | 1.19(0.44~3.29) | 1.42(0.43~4.67) | 1.29(0.38~4.33) |
Q3 | 5.09(1.96~13.23)a | 3.21(1.18~8.74)a | 3.48(1.08~11.25)a | 2.58(0.73~9.13) |
年龄≥30岁(以Q1为参照) | ||||
Q2 | 2.75(1.02~7.38)a | 1.74(0.62~4.87) | 0.97(0.44~2.15) | 0.82(0.36~1.88) |
Q3 | 8.17(3.02~22.14)a | 5.68(2.03~15.92)a | 1.47(0.62~3.48) | 1.02(0.40~2.56) |
血清尿酸/肌酐 | ||||
年龄<30岁(以q1为参照) | ||||
q2 | 1.97(0.71~5.42) | 1.41(0.49~4.10) | 1.18(0.31~4.59) | 1.03(0.25~18.63) |
q3 | 4.42(1.57~12.46)a | 2.78(0.93~8.25) | 5.28(1.47~19.02)a | 3.59(0.93~13.79) |
年龄≥30岁(以q1为参照) | ||||
q2 | 3.32(1.34~8.21)a | 3.38(1.25~9.17)a | 1.11(0.48~2.57) | 1.01(0.43~2.39) |
q3 | 5.21(2.02~13.44)a | 4.24(1.48~12.16)a | 2.31(0.98~5.45) | 1.91(0.77~4.71) |
变量 | 子痫前期 | 早产 | ||
---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸 | ||||
初产妇(以Q1为参照) | ||||
Q2 | 2.33(1.05~5.18)a | 1.58(0.68~3.66) | 1.47(0.57~3.82) | 1.16(0.44~3.07) |
Q3 | 6.46(2.89~14.39)a | 4.36(1.89~10.09)a | 3.53(1.37~9.08)a | 2.50(0.93~6.72) |
经产妇(以Q1为参照) | ||||
Q2 | 1.49(0.38~5.88) | 0.95(0.22~4.09) | 1.02(0.38~2.72) | 1.02(0.37~2.79) |
Q3 | 4.78(1.20~18.99)a | 3.19(0.75~13.52) | 0.73(0.20~2.67) | 0.62(0.16~2.45) |
血清尿酸/肌酐 | ||||
初产妇(以q1为参照) | ||||
q2 | 3.12(1.36~7.15)a | 2.73(1.14~6.55)a | 1.56(0.56~4.36) | 1.35(0.47~3.86) |
q3 | 6.26(2.67~14.70)a | 4.61(1.86~11.41)a | 4.95(1.81~13.51)a | 4.02(1.41~11.45)a |
经产妇(以q1为参照) | ||||
q2 | 1.39(0.41~4.69) | 1.59(0.40~6.29) | 0.79(0.27~2.37) | 0.76(0.25~2.33) |
q3 | 1.80(0.47~6.83) | 1.64(0.35~7.61) | 1.86(0.61~5.72) | 1.93(0.61~6.10) |
Table 4 Effects of serum uric acid and serum uric acid/creatinine ratio on preeclampsia and preterm birth in different subgroups of pregnancies and deliveries
变量 | 子痫前期 | 早产 | ||
---|---|---|---|---|
OR(95%CI) | AOR(95%CI) | OR(95%CI) | AOR(95%CI) | |
血清尿酸 | ||||
初产妇(以Q1为参照) | ||||
Q2 | 2.33(1.05~5.18)a | 1.58(0.68~3.66) | 1.47(0.57~3.82) | 1.16(0.44~3.07) |
Q3 | 6.46(2.89~14.39)a | 4.36(1.89~10.09)a | 3.53(1.37~9.08)a | 2.50(0.93~6.72) |
经产妇(以Q1为参照) | ||||
Q2 | 1.49(0.38~5.88) | 0.95(0.22~4.09) | 1.02(0.38~2.72) | 1.02(0.37~2.79) |
Q3 | 4.78(1.20~18.99)a | 3.19(0.75~13.52) | 0.73(0.20~2.67) | 0.62(0.16~2.45) |
血清尿酸/肌酐 | ||||
初产妇(以q1为参照) | ||||
q2 | 3.12(1.36~7.15)a | 2.73(1.14~6.55)a | 1.56(0.56~4.36) | 1.35(0.47~3.86) |
q3 | 6.26(2.67~14.70)a | 4.61(1.86~11.41)a | 4.95(1.81~13.51)a | 4.02(1.41~11.45)a |
经产妇(以q1为参照) | ||||
q2 | 1.39(0.41~4.69) | 1.59(0.40~6.29) | 0.79(0.27~2.37) | 0.76(0.25~2.33) |
q3 | 1.80(0.47~6.83) | 1.64(0.35~7.61) | 1.86(0.61~5.72) | 1.93(0.61~6.10) |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] | |
[6] |
谢幸,孔北华,段涛. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
ACOG practice bulletin No. 202:gestational hypertension and preeclampsia[J]. Obstet Gynecol,2019,133(1):1. DOI:10.1097/AOG.0000000000003018.
|
[15] |
|
[16] |
|
[17] |
Macrosomia:ACOG practice bulletin,number 216[J]. Obstet Gynecol,2020,135(1):e18-35. DOI:10.1097/AOG.0000000000003606.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
吕琳,艾玲,平泽朋. 孕妇血清尿酸水平与妊娠期高血压疾病严重程度的相关性分析[J]. 中国妇幼保健,2021,36(24):5649-5651. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.24.013.
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
黄琼辉,刘捷,曾超美,等. 母体高尿酸血症对妊娠结局和新生儿合并症影响的回顾性巢式病例对照研究[J]. 中国循证儿科杂志,2022,17(5):331-335. DOI:10.3969/j.issn.1673-5501.2022.05.002.
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[1] | SHANG Jinmeng, DENG Xiaowei. Characteristics and Risk Factors of Preserved Ratio Impaired Spirometry in Physical Examination Population [J]. Chinese General Practice, 2024, 27(11): 1331-1336. |
[2] | KANG Jing, ZHANG Ci, ZHANG Zhengyi. Distribution and Influencing Factors of Chronic Comorbidities among Middle-aged Inpatients in General Practice Department of Tertiary General Hospitals [J]. Chinese General Practice, 2024, 27(11): 1310-1315. |
[3] | HE Haiyang, YANG Jialing, LEI Xun. Prevalence and Influencing Factors of Osteoporosis in Postmenopausal Women: a Meta-analysis [J]. Chinese General Practice, 2024, 27(11): 1370-1379. |
[4] | WEN Jing, ZHANG Yue, LIANG Xuyang, LYU Shengxiang. Study on the Influencing Factors of Gastric Cancer Based on Opportunistic Screening of Upper Gastrointestinal Cancer in Coastal Area of Northern Jiangsu [J]. Chinese General Practice, 2024, 27(09): 1042-1047. |
[5] | FAN Jing, WEI Shan, LI Liqiu, ZHENG Xiuli, LI Yan, NIU Jianying, WANG Ling, XU Chengyan. Investigation on the Incidence and Influencing Factors of Proteinuria and Renal Dysfunction in Community-dwelling Elderly Population [J]. Chinese General Practice, 2024, 27(09): 1048-1053. |
[6] | WU Shuqin, WANG Yuanhan, ZHENG Kaiyuan, HAN Hongjuan, KANG Jinxiu, YU Hongmei. Prognosis and Influencing Factors of Patients with Malignant Melanoma [J]. Chinese General Practice, 2024, 27(08): 942-947. |
[7] | ZHANG Yafang, WEN Xuan, YANG Zhongting, DU Xingmei, DENG Chunyan, YE Qingyun, DENG Rui, HUANG Yuan. Impact of Household Income Levels on Successful Aging of the Elderly [J]. Chinese General Practice, 2024, 27(08): 930-935. |
[8] | LIU Ying, JIANG Juncheng, JING Huiquan. Regional Differences in Disability and Its Influencing Factors among Middle-aged and Elderly People in East, Central and West Major Regions in China [J]. Chinese General Practice, 2024, 27(07): 877-885. |
[9] | YANG Huajie, WANG Haoxiang, CHEN Yuncong, LIANG Xudong, WANG Jiaji, HUANG Xiang. Status and Influencing Factors of Mental Health of Community Medical Personnel during the Normalized Prevention and Control of COVID-19 [J]. Chinese General Practice, 2024, 27(07): 834-842. |
[10] | LIU Yang, WANG Yu, CONG Jing, GONG Yi, HAN Buwei, WANG Kaiyue, ZHU Mengyi, ZHANG Bei, WU Xiaoke. Analysis of Factors Influencing Hyperlipidemia in Female Polycystic Ovary Syndrome Patients with Normal Body Mass Index [J]. Chinese General Practice, 2024, 27(06): 717-722. |
[11] | SUN Yuxin, ZHAN Haoran, AYIXIAMU· Keyimu, XU Tingting. Maternal Quality of Life and Influencing Factors in Rural China [J]. Chinese General Practice, 2024, 27(06): 656-662. |
[12] | ZHENG Kui, LIU Lu, WANG Yongli, LI Hui, WANG Xuan, LI Bo, HAO Jingxia, ZHANG Yingqian. Genetic Etiology and Risk Factors for Mortality in Primary Dilated Cardiomyopathy in Children [J]. Chinese General Practice, 2024, 27(06): 679-684. |
[13] | YUAN Xianxian, LI Jing, WANG Jia, ZHANG Kexin, YANG Ruihua, ZHENG Wei, LI Guanghui. Prevalence of Dyslipidemia in Pregnancy and Early Predictive Value of Blood Lipid Levels [J]. Chinese General Practice, 2024, 27(06): 670-678. |
[14] | JIA Liyan, ZHAO Nengjiang, YAN Bing, ZHANG Zhihai, ZHAN Na, LIN Yuanbing, LIU Jianping, YANG Shuyu. Analysis of the Factors Impacting the Awareness and Utilization of Traditional Chinese Medicine Guidelines for Diabetes among Primary Care Practitioners [J]. Chinese General Practice, 2024, 27(05): 589-596. |
[15] | CHEN Lijiang, HU Chuanfeng, TANG Jing, ZHENG Ruini, GUAN Xueling, HUANG Wenhao, QIN Zhaohui. The Patient Satisfaction and Its Influencing Factors in Compact County Medical Community Based on Anderson Model [J]. Chinese General Practice, 2024, 27(04): 427-453. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||